Clinical trials: Submucosal Tumor
Neoplasms, Colorectal
Endoscopic Mucosal Resection Versus Endoscopic Submucosal Dissection for Colorectal Laterally Spreading Lesions.
EMR and ESD are both effective and safe and are associated with a very low risk of procedure related mortality when performed for colorectal laterally spreading lesions (LSL).
- Trial name
- intERsection (NCT04593407)
- Testing
- Endoscopic mucosal resection (EMR), Endoscopic submucosal dissection (ESD)
- Where
- Spain
- Volunteers
- 236 people
- Sponsor
- José Carlos Marín Gabriel
Esophageal Lesion, Barrett Esophagus
Endoscopic Submucosal Dissection (ESD)
This registry is to evaluate the procedural and clinical outcomes in patients undergoing endoscopic submucosal dissection. All patients will receive standard of medical care and no experimental interventions will be performed.
- Conditions
- Esophageal Lesion, Barrett Esophagus, Gastrointestinal Lesions
- Trial name
- ESD (NCT05468008)
- Testing
- Endoscopic Submucosal Dissection
- Where
- United States
- Volunteers
- 1,000 people
- Sponsor
- AdventHealth
Rectal Neuroendocrine Tumor
Endoscopic Treatment of Rectal Neuroendocrine Tumor(NET) Less Than 10mm
Cap-assisted endoscopic mucosal resection (EMR-C) and endoscopic submucosal dissection (ESD) have both been reported to be effective treatment methods for small rectal neuroendocrine tumor (NET) in limited studies.
- Trial name
- NCT03982264
- Testing
- ESD procedure, EMR-C procedure
- Volunteers
- 90 people
- Sponsor
- Nanfang Hospital, Southern Medical University
Colorectal Neoplasms, Endoscopic Submucosal Dissection
Evaluation of Endoscopic Submucosal Dissection (ESD) Efficacy
Superficial rectal tumors could be removed by ESD with two major advantages showed by the literature: high rate of monobloc resection and R0 resection. Hence, recurrence rate was lower than ERM therapy.
- Trial name
- DISSECMUC (NCT01879904)
- Testing
- Endoscopic submucosal dissection (ESD)
- Where
- France
- Volunteers
- 48 people
- Sponsor
- Assistance Publique - Hôpitaux de Paris
Colorectal Neoplasms
Follow-up After Oncological Resection by Endoscopic Colorectal ESD (Endoscopic Submucosal Dissection)
Colorectal cancer is a common and leading cause of death. Pre-cancerous lesions, as well as some so-called superficial cancers, can be resected via endoscopy.
- Trial name
- FORCE (NCT07871227)
- Testing
- Surgery, Radiochimiotherapy
- Where
- 14 sites in France
- Volunteers
- 1,200 people
- Sponsor
- University Hospital, Bordeaux
Esophageal Cancer
Adjuvant Radiotherapy for pT1b Esophageal Cancer After Submucosal Endoscopic Resection
Endoscopic Resection (ER) is a crucial therapeutic and diagnostic method for superficial esophageal cancer. However, lymph node metastasis rate in pT1b patients is relatively high.
- Trial name
- NCT05499195
- Where
- China
- Volunteers
- 159 people
- Sponsor
- Chinese Academy of Medical Sciences
Colorectal Tumor
Transanal Tube Drainage in Endoscopic Submucosal Dissection of the Colorectal Tumor
We design the clincal trial to investigate the efficacy of transanal tube drainage in colorectal ESD.
- Trial name
- NCT02973490
- Testing
- Transanal Tube Drainage
- Where
- China
- Volunteers
- 1,200 people
- Sponsor
- Fudan University
Esophageal Cancer
SLND Versus Non-Dissection Following ESD for T1a Stage Esophageal Squamous Cell Carcinoma
This is a study from Fujian Cancer Hospital Thoracic of Surgery Project, numbered as FJCHTOSP-1. Systematically mediastinal Lymph Node Dissection (SLD) Versus Non-Dissection Following Endoscopic Submucosal Dissection (ESD) for…
- Trial name
- NCT06979986
- Testing
- Endoscopic Submucosal Dissection with Systematically mediastinal Lymph Node Dissection, Endoscopic Submucosal Dissection without SLND
- Volunteers
- 102 people
- Sponsor
- Fujian Cancer Hospital
Pancreatic Cyst, Pancreatic Neoplasms
Clinical Registry of nCLE in Masses and Cystic Tumors of the Pancreas, Lymph Nodes, Submucosal Lesions of the GI Tract
This study focuses on four different lesions: pancreatic cysts, lymph nodes near the gastrointestinal tract, pancreatic masses and GIST tumors.
- Conditions
- Pancreatic Cyst, Pancreatic Neoplasms, Pancreatic Adenoma, Pancreatic Cancer
- Trial name
- US-nCLE (NCT01770405)
- Testing
- Endoscopic ultrasound fine needle aspiration
- Where
- 4 sites in United States
- Volunteers
- 40 people
- Sponsor
- Mauna Kea Technologies
Rectal Neuroendocrine Tumor
Endoscopic Resection for Small Rectal Neuroendocrine Tumors
In previous single center study, both modified cap-assisted endoscopic mucosal resection (mEMR-C) and endoscopic submucosal dissection (ESD) were reported to be effective for the treatment of small rectal neuroendocrine tumors…
- Trial name
- NCT05429216
- Testing
- mEMR-C procedure, ESD procedure
- Volunteers
- 102 people
- Sponsor
- Nanfang Hospital, Southern Medical University
Colon Polyp, Colon Neoplasia
Prospective Study of Using Novel Bipolar Scissors in Colorectal Endoscopic Submucosal Dissection
This study is an interventional, prospective, single-center study to evaluate the safety and effectiveness of a novel radiofrequency and microwave ablation flexible bipolar (SpydrBlade Flex, CREO Medical, UK) for colorectal ESD…
- Trial name
- NCT06715332
- Testing
- Colorectal ESD with SpydrBlade Flex
- Where
- Hong Kong
- Volunteers
- 30 people
- Sponsor
- Chinese University of Hong Kong
Gastric Neoplasm, Esophageal Neoplasms
Non-curative ESDs: Assessing the Rates and Risk Factors for Residual Neoplasia
Short and long outcomes of ESD are well described, particularly in Eastern series. However, the outcome of non-curative ESDs is scarcely reported in the west (particularly among non-gastric or submucosal lesions).
- Conditions
- Gastric Neoplasm, Esophageal Neoplasms, Colorectal Neoplasms
- Trial name
- NC-ESD (NCT04484311)
- Where
- Portugal
- Volunteers
- 300 people
- Sponsor
- Universidade do Porto
Gastrointestinal Neoplasms
Utility of OverStitch Sx After ESD
This study is a prospective study where the investigators will make a database of all the patients who have received this procedure and will document various outcomes (i.e.
- Trial name
- NCT04361227
- Where
- United States
- Volunteers
- 33 people
- Sponsor
- Baylor College of Medicine
Colorectal Neoplasia, Colorectal Superficial Neoplasia
Trial of Underwater Versus Gas-Insufflation Colorectal Endoscopic Submucosal DisseEtion
Colorectal endoscopic submucosal dissection (ESD) enables en bloc resection of large superficial colorectal neoplasia but remains technically demanding and may be limited by suboptimal visualization, intraprocedural bleeding…
- Conditions
- Colorectal Neoplasia, Colorectal Superficial Neoplasia, Colorectal Precancerous Lesions
- Trial name
- TIDE (NCT07490574)
- Testing
- Underwater ESD (UESD), Conventional Gas-Assisted ESD (GESD)
- Where
- Italy
- Volunteers
- 295 people
- Sponsor
- University of Roma La Sapienza
Colorectal Cancer (MSI-H)
Assessment of a New Traction Device in Submucosal Dissection of Colorectal Lesions
Colorectal cancer is a major public health issue. In France, in 2015, there were 40,000 new cases and 17,000 deaths. It develops from adenomas or scalloped polyps, which are usually accessible for endoscopic resection.
- Trial name
- COLOTRACT (NCT07263997)
- Testing
- SureTrac is designed to perform single or multi-polar traction and to adjust the traction intensity during dissection.
- Where
- France
- Volunteers
- 30 people
- Sponsor
- GCS Ramsay Santé pour l'Enseignement et la Recherche
Early Gastric Cancer Patients Who Were Scheduled for Endoscopic Submucosal Dissection
A Comparison of Efficacy and Safety During Endoscopic Submucosal Dissection Between Dexmedetomidine-remifentanil and Propofol-remifentanil
Adequate, safe sedation is essential for Endoscopic submucosal dissection. Dexmedetomidine is a potent and selective a2-adrenoceptor agonist used for sedative and analgesic effects, but it is limited to use alone.
- Trial name
- NCT01920113
- Testing
- Dexmedetomidine - remifentanil group, Propofol - remifentanil group
- Where
- South Korea
- Volunteers
- 60 people
- Sponsor
- Yonsei University
Esophageal Stricture
Effect of a Combination of Local Steroid Injection With Oral Steroid Administration for the Prevention on Esophageal Stricture After Endoscopic Submucosal Dissection for Early Esophageal Neoplasm
The method of esophageal endoscopic submucosal dissection (ESD) to remove superficial esophageal neoplasms has gained widespread acceptance as an alternative to surgery recently these years especially in Asian countries.
- Trial name
- NCT03039608
- Testing
- combination of local steroid injection（triamcinolone ）with oral steroid administration（prednisone）, oral steroid administration（prednisone）
- Where
- China
- Volunteers
- 72 people
- Sponsor
- Shanghai Zhongshan Hospital
Gastrointestinal Neoplasm
Novel Rigidizing Overtube in Colonic Endoscopic Submucosal Dissection
The goal of this prospective, single centre, 1:1, Post Market, randomized controlled, Investigator Initiated trial, is to compare the feasibility, safety efficacy, and clinical outcomes of colonic endoscopic submucosal dissection…
- Trial name
- NCT06134687
- Testing
- Endoscopic Submucosal Dissection, Novel Rigidizing Overtube
- Where
- 2 sites in United States
- Volunteers
- 66 people
- Sponsor
- Baylor College of Medicine
Gastric Dysplasia, Gastric Cancer in Situ
Endoscopic Closure of Gastric ESD Defect
This is a pilot study to investigate the usefulness of closure of mucosal defect after gastric endoscopic submucosal dissection (ESD) in patients that are at high risk of post-procedural haemorrhage.
- Trial name
- NCT04282707
- Testing
- Endoscopic closure of ESD defect, Gastric ESD without closure of ESD defect
- Where
- Hong Kong
- Volunteers
- 30 people
- Sponsor
- Chinese University of Hong Kong
Benign Neoplasm, Pathology
Deep Biopsy Via Endoscopic Submucosal Dissection in Upper GI Subepithelial Tumors
Upper gastrointestinal subepithelial tumors are frequently encountered during esophagogastroduodenoscopy. Treatment plans for subepithelial tumors are determined by algorithms based on endoscopic ultrasonography images.
- Trial name
- NCT01993199
- Testing
- deep biopsy via ESD technique
- Volunteers
- 40 people
- Sponsor
- Hanyang University Seoul Hospital